TriangleNCT02151981 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- other Details
- The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review, should the submission for publication be delayed in order to file patent application. The sponsor cannot require changes to the communication and cannot extend the embargo.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- information.center@astrazeneca.com
- organization
- AstraZeneca Clinical Study Information Center
- phone
- 1-877-240-9479
- title
- Global Clinical Lead
Complete source fields
- certain Agreement
- other Details
- The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review, should the submission for publication be delayed in order to file patent application. The sponsor cannot require changes to the communication and cannot extend the embargo.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- information.center@astrazeneca.com
- organization
- AstraZeneca Clinical Study Information Center
- phone
- 1-877-240-9479
- title
- Global Clinical Lead
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice